Small Molecule Drugs for Obesity: A Scalable, Oral Alternative to Peptide-Based Therapies
Obesity remains one of the most pressing public health crises of the current time. Beyond the difficulty of achieving weight loss, long-term weight maintenance remains a major hurdle - data shows that up to 80% of lost weight is regained within five years
August 22, 2025
by Neeta Ratanghayra
The Race to Reinvent Antibiotics: Why Innovation and Access Must Go Hand in Hand
Register to Download PPT and View Why Innovation and Access Must Go Hand in Hand
April 9, 2025
by Neeta Ratanghayra
Cell and Gene Therapy Manufacturing: Operational Challenges and Strategic Considerations
Producing CGTs requires highly specialized infrastructure, precise processes, and significant investments, making the manufacturing landscape both complex and costly.
December 20, 2024
by Neeta Ratanghayra
Charting Pharma’s Future: How Mergers and Acquisitions Are Reshaping the Industry Landscape
In Q3 2024 (GlobalData’s Deals Database), the pharmaceutical sector saw 420 M&A deals valued at $32.4 billion, underscoring the ongoing importance of these transactions in shaping the future of the industry.
December 17, 2024
by Neeta Ratanghayra
Decoding the Role of Synthetic Biology in Pharmaceuticals
Recognized for its transformative potential, synthetic biology has emerged as a technology poised to revolutionize various industries, including pharmaceuticals.
October 16, 2024
by Neeta Ratanghayra
Navigating the Landscape of Rare Diseases: Current Trends and Future Perspectives
Rising Investment and Market Dynamics, Future Perspectives in the Orphan Drug Market and The Scenario in China.
September 29, 2024
by Neeta Ratanghayra
Immuno-Oncology: Current Market Landscape and Future Trends(1)
Immune Checkpoint Inhibitors & Challenges and Future Directions.
September 18, 2024
by Neeta Ratanghayra
Immuno-Oncology: Current Market Landscape and Future Trends(2)
CAR-T Therapy & Antibody–Drug Conjugates.
September 18, 2024
by Neeta Ratanghayra
Gut Hormone-Based Pharmacotherapies for Obesity
The history of pharmacotherapy for obesity is marked by a series of promising drugs that were withdrawn due to safety concerns.
April 28, 2024
by Neeta Ratanghayra
The Evolving Landscape of Heart Failure Therapies
Heart failure (HF) is a leading cause of disability worldwide and has a major impact on the global economy and healthcare systems.
January 31, 2024
by Neeta Ratanghayra
Antibody-Drug Conjugates - Lessons Learned
Antibody-drug conjugates (ADCs) have made significant progress in tumor therapy and show a promising future.
May 20, 2022
by Neeta Ratanghayra
Trends and Developments in HIV Research
Novel treatment strategies and advances in care have transformed the lives of people living with HIV (human immunodeficiency virus). Antiretroviral therapy (ART), once-daily single-tablet regimens (STRs)...
March 30, 2022
by Neeta Ratanghayra